Palpitations: Evaluation, Management, and Wearable Smart Devices

Robert L. Gauer, MD
Melanie F. Thomas, DO
Ryan A. McNutt, MD

American Family Physician. 2024;110(3):259-269.

Author disclosure: No relevant financial relationships.

This clinical content conforms to AAFP criteria for CME.

Palpitations are a common symptom described by patients as a feeling of a racing or fluttering heart, a pounding chest, irregular or skipped heartbeats, or a pounding sensation in the neck. They are associated with a low mortality rate; however, recurrent palpitations have been shown to impair quality of life and increase health care use. Common triggers are cardiac disorders, endocrine and metabolic disorders, medication or illicit drug use, or psychosomatic disorders. A detailed history, physical examination, directed laboratory studies, and 12-lead electrocardiography are often sufficient to identify the etiology of palpitations. Additional testing may be indicated to include echocardiography, cardiac stress testing, electrocardiogram monitoring, or electrophysiologic studies to distinguish whether symptoms correlate with cardiac arrhythmia or structural or ischemic heart disease. Management of palpitations is based on the suspected etiology. In most cases of cardiac-induced palpitations, the treatment can include reassurance, education, trigger avoidance, or use of atrioventricular nodal blockers. Tachyarrhythmias may require cardiac ablation. Patients who have palpitations with no arrhythmia causality and no cardiac disease should be reassured; however, screening for psychosomatic disorders should be considered. Wearable smart devices with ambulatory electrocardiogram monitoring technologies are currently available to consumers; these tools have shown diagnostic accuracy for detection of arrhythmias, allowing patients to have greater participation in their health care.

Am Fam Physician. 2024; 110(3):259–269. Copyright © 2024 American Academy of Family Physicians.

ROBERT L. GAUER, MD, is a hospitalist in the Department of Internal Medicine Residency program at Womack Army Medical Center, Fort Liberty, N.C., and an assistant professor of family medicine at the Uniformed Services University of the Health Sciences, Bethesda, Md.

MELANIE F. THOMAS, DO, is a resident in the Department of Internal Medicine at Womack Army Medical Center.

RYAN A. MCNUTT, MD, is a resident in the Department of Internal Medicine at Womack Army Medical Center.

Address correspondence to Robert L. Gauer, MD, at robertgauer@yahoo.com.

Author disclosure: No relevant financial relationships.

  1. 1.Probst MA, Mower WR, Kanzaria HK, et al. Analysis of emergency department visits for palpitations (from the National Hospital Ambulatory Medical Care Survey). Am J Cardiol. 2014;113(10):1685-1690.
  2. 2.Wilken J. Evidence-based recommendations for the evaluation of palpitations in the primary care setting. Med Clin North Am. 2016;100(5):981-989.
  3. 3.Lenderink T, Balkestein EJM. First time referral reasons, diagnoses and 10-year follow-up of patients seen at a Dutch fast lane outpatient cardiology clinic. Neth Heart J. 2019;27(7–8):354-361.
  4. 4.Zimetbaum P, Josephson ME. Evaluation of patients with palpitations. N Engl J Med. 1998;338(19):1369-1373.
  5. 5.Francisco-Pascual J, Cantalapiedra-Romero J, Pérez-Rodon J, et al. Cardiac monitoring for patients with palpitations. World J Cardiol. 2021;13(11):608-627.
  6. 6.Raviele A, Giada F, Bergfeldt L, et al. Management of patients with palpitations. Europace. 2011;13(7):920-934.
  7. 7.Weber BE, Kapoor WN. Evaluation and outcomes of patients with palpitations [published correction appears in Am J Med. 1997; 103(1): 86]. Am J Med. 1996;100(2):138-148.
  8. 8.Giada F, Raviele A. Clinical approach to patients with palpitations. Card Electrophysiol Clin. 2018;10(2):387-396.
  9. 9.Weinstock C, Wagner H, Snuckel M, et al. Evidence-based approach to palpitations. Med Clin North Am. 2021;105(1):93-106.
  10. 10.Probst MA, Kanzaria HK, Hoffman JR, et al. Emergency physicians’ perceptions and decision-making processes regarding patients presenting with palpitations. J Emerg Med. 2015;49(2):236.e2-243.e2.
  11. 11.Probst MA, Carpenter CR. Palpitations. In: Pines JM, Raja AS, Carpenter CR, et al., eds. Evidence-Based Emergency Care: Diagnostic Testing and Clinical Decision Rules. 3rd ed. John Wiley and Sons, Ltd; 2023: 276–286.
  12. 12.Narducci D, Patil S, Zeitler M, et al. Is an underlying cardiac condition causing your patient’s palpitations?. J Fam Pract. 2021;70(2):60-68.
  13. 13.Evans T, Holdsworth DA, Jackson S, et al. Managing palpitations in the military patient. J R Army Med Corps. 2015;161(3):192-199.
  14. 14.Thavendiranathan P, Bagai A, Khoo C, et al. Does this patient with palpitations have a cardiac arrhythmia?. JAMA. 2009;302(19):2135-2143.
  15. 15.Dani M, Dirksen A, Taraborrelli P, et al. Autonomic dysfunction in ‘long COVID.’. Clin Med (Lond). 2021;21(1):e63-e67.
  16. 16.Alijaniha F, Noorbala A, Afsharypuor S, et al. Relationship between palpitation and mental health. Iran Red Crescent Med J. 2016;18(3):e22615.
  17. 17.Gale CP, Camm AJ. Assessment of palpitations. BMJ. 2016;352:h5649.
  18. 18.Jamshed N, Dubin J, Eldadah Z. Emergency management of palpitations in the elderly. Clin Geriatr Med. 2013;29(1):205-230.
  19. 19.Crawford MH, Bernstein SJ, Deedwania PC, et al. ACC/AHA guidelines for ambulatory electrocardiography. Circulation. 1999;100(8):886-893.
  20. 20.Steinberg JS, Varma N, Cygankiewicz I, et al. 2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry. Ann Noninvasive Electrocardiol. 2017;22(3):e12447.
  21. 21.Quan KJ. Palpitation: extended electrocardiogram monitoring: which tests to use and when. Med Clin North Am. 2019;103(5):785-791.
  22. 22.Radovanović NN, Pavlović SU, Kirćanski B, et al. Diagnostic value of implantable loop recorders in patients with unexplained syncope or palpitations. Ann Noninvasive Electrocardiol. 2021;26(5):e12864.
  23. 23.Brignole M, Moya A, de Lange FJ, et al.; ESC Scientific Document Group. 2018 ESC guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39(21):1883-1948.
  24. 24.McLellan AJ, Kalman JM. Approach to palpitations. Aust J Gen Pract. 2019;48(4):204-209.
  25. 25.Govender I, Nashed KK, Rangiah S, et al. Palpitations. S Afr Fam Pract (2004). 2022;64(1):e1-e8.
  26. 26.Wexler RK, Pleister A, Raman SV. Palpitations: evaluation in the primary care setting. Am Fam Physician. 2017;96(12):784-789.
  27. 27.Michaud GF, Stevenson WG. Atrial fibrillation. N Engl J Med. 2021;384(4):353-361.
  28. 28.Diamant MJ, Andrade JG, Virani SA, et al. Heart failure and atrial flutter. ESC Heart Fail. 2021;8(6):4484-4496.
  29. 29.Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation [published correction appears in Circulation. 2024 ;149(1):e167]. Circulation. 2024;149(1):e1-e156.
  30. 30.Guichard JB, Guasch E, Roche F, et al. Premature atrial contractions. Front Physiol. 2022;13:971691.
  31. 31.Sasaki K, Nakajima I, Higuma T, et al. Revisit to the prognostic value of premature atrial contraction burden in 24-h Holter electrocardiography for predicting undiagnosed atrial fibrillation—a propensity score-matched study. Circ J. 2021;85(8):1265-1272.
  32. 32.Huang TC, Lee PT, Huang MS, et al. The beneficial effects of beta blockers on the long-term prognosis of patients with premature atrial complexes. Front Cardiovasc Med. 2022;9:806743.
  33. 33.Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death [published correction appears in J Am Coll Cardiol. 2018; 72(14):1760]. J Am Coll Cardiol. 2018;72(14):e91-e220.
  34. 34.Arnar DO, Mairesse GH, Boriani G, et al.; ESC Scientific Document Group; EHRA Scientific Documents Committee. Management of asymptomatic arrhythmias. Europace. 2019;21(6):844-845.
  35. 35.Higuchi K, Bhargava M. Management of premature ventricular complexes. Heart. 2022;108(7):565-572.
  36. 36.Brugada J, Katritsis DG, Arbelo E, et al. 2019 ESC guidelines for the management of patients with supraventricular tachycardia [published correction appears in Eur Heart J. 2020; 41(44):4258]. Eur Heart J. 2020;41(5):655-720.
  37. 37.Marcus GM. Evaluation and management of premature ventricular complexes. Circulation. 2020;141(17):1404-1418.
  38. 38.Kusumoto FM, Schoenfeld MH, Barrett C, et al. 2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay [published correction appears in Circulation. 2019;140:e506–e508]. Circulation. 2019;140(8):e382-e482.
  39. 39.Ahmed A, Pothineni NVK, Charate R, et al. Inappropriate sinus tachycardia. J Am Coll Cardiol. 2022;79(24):2450-2462.
  40. 40.Sharma G, Mooventhan A, Naik G, et al. A review on role of yoga in the management of patients with cardiac arrhythmias. Int J Yoga. 2021;14(1):26-35.
  41. 41.Kandiah JW, Blumberger DM, Rabkin SW. The fundamental basis of palpitations. Curr Cardiol Rev. 2022;18(3):e090921196306.
  42. 42.U.S. Preventive Services Task Force. Atrial fibrillation. January 25, 2022. Accessed April 17, 2024. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/atrial-fibrillation-screening
  43. 43.Gajda R, Gajda J, Czuba M, et al. Sports heart monitors as reliable diagnostic tools for training control and detecting arrhythmias in professional and leisure-time endurance athletes: an expert consensus statement. Sports Med. 2024;54(1):1-21.
  44. 44.Singh M, Rao R, Gupta S. KardiaMobile for ECG monitoring and arrhythmia diagnosis. Am Fam Physician. 2020;102(9):562-564.
  45. 45.Alnasser S, Alkalthem D, Alenazi S, et al. The reliability of the Apple Watch’s electrocardiogram. Cureus. 2023;15(12):e49786.
  46. 46.Mohamoud A, Jensen J, Buda KG. Consumer-grade wearable cardiac monitors. Cleve Clin J Med. 2024;91(1):23-29.
  47. 47.Baman JR, Mathew DT, Jiang M, et al. Mobile health for arrhythmia diagnosis and management. J Gen Intern Med. 2022;37(1):188-197.
  48. 48.Mairesse GH, Moran P, Van Gelder IC, et al. Screening for atrial fibrillation [published correction appears in Europace. 2018; 20(4): 658]. Europace. 2017;19(10):1589-1623.
  49. 49.Salar Alcaraz ME, Buendía Santiago F, Flores Blanco PJ, et al. Usefulness of a smartphone-based event recorder for ambulatory patients with palpitations. Rev Esp Cardiol (Engl Ed). 2021;74(12):1114-1116.
  50. 50.Narasimha D, Hanna N, Beck H, et al. Validation of a smartphone-based event recorder for arrhythmia detection. Pacing Clin Electrophysiol. 2018;41(5):487-494.
  51. 51.Nazarian S, Lam K, Darzi A, et al. Diagnostic accuracy of smart-watches for the detection of cardiac arrhythmia: systematic review and meta-analysis. J Med Internet Res. 2021;23(8):e28974.
  52. 52.Gibson CM, Steinhubl S, Lakkireddy D, et al.; Heartline Steering Committee. Does early detection of atrial fibrillation reduce the risk of thromboembolic events?. Am Heart J. 2023;259:30-41.
  53. 53.Hughes A, Shandhi MMH, Master H, et al. Wearable devices in cardiovascular medicine. Circ Res. 2023;132(5):652-670.
  54. 54.Abbott AV. Diagnostic approach to palpitations. Am Fam Physician. 2005;71(4):743-750.

Copyright © 2026 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.